Search research articles
Contact Us
Filters
Showing results (911-920 of 1,023) with videos related to
Page
of 103
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
D Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Nature Medicine
|
September 6, 2000
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
M D Hazenberg, S A Otto, J W Cohen Stuart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR
Ezra E W Cohen, Mark W Lingen, Leslie E Martin, et al.
The Journal of Clinical Investigation
|
December 1, 2021
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial
Suzanne L Campion, Elena Brenna, Elaine Thomson, et al.
Plos One
|
February 2, 2011
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel
Marla J Keller, Rebecca P Madan, N Merna Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer
Ezra E W Cohen, Daniel J Haraf, Rangesh Kunnavakkam, et al.
Plos One
|
October 5, 2022
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
Viki Bockstal, Georgi Shukarev, Chelsea McLean, et al.
Journal of General Internal Medicine
|
March 11, 2021
Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry
Christopher B Forrest, Haolin Xu, Laine E Thomas, et al.
Annals of the American Thoracic Society
|
April 21, 2016
Blood Eosinophils and World Trade Center Exposure Predict Surgery in Chronic Rhinosinusitis. A 13.5-Year Longitudinal Study
Sophia Kwon, Barbara Putman, Jessica Weakley, et al.
Journal of the American Society of Nephrology : JASN
|
February 20, 2010
Pathologic classification of diabetic nephropathy
Thijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, et al.
Page
of 103
Search research articles
Search
Showing results (911-920 of 1,023) with videos related to
Sort By:
Page
of 103
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
D Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Nature Medicine
|
September 6, 2000
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
M D Hazenberg, S A Otto, J W Cohen Stuart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR
Ezra E W Cohen, Mark W Lingen, Leslie E Martin, et al.
The Journal of Clinical Investigation
|
December 1, 2021
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial
Suzanne L Campion, Elena Brenna, Elaine Thomson, et al.
Plos One
|
February 2, 2011
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel
Marla J Keller, Rebecca P Madan, N Merna Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer
Ezra E W Cohen, Daniel J Haraf, Rangesh Kunnavakkam, et al.
Plos One
|
October 5, 2022
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
Viki Bockstal, Georgi Shukarev, Chelsea McLean, et al.
Journal of General Internal Medicine
|
March 11, 2021
Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry
Christopher B Forrest, Haolin Xu, Laine E Thomas, et al.
Annals of the American Thoracic Society
|
April 21, 2016
Blood Eosinophils and World Trade Center Exposure Predict Surgery in Chronic Rhinosinusitis. A 13.5-Year Longitudinal Study
Sophia Kwon, Barbara Putman, Jessica Weakley, et al.
Journal of the American Society of Nephrology : JASN
|
February 20, 2010
Pathologic classification of diabetic nephropathy
Thijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, et al.
Page
of 103